Opthea Presents Positive Data from Wet AMD Trial at EURETINA
6 September 2019 Melbourne, Australia; – Opthea Limited (ASX:OPT), a clinical biopharmaceutical company developing novel biologic therapies for eye diseases, announced today that new clinical data from its completed 366 patient Phase 2b randomised, controlled study of OPT-302…
The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy
5 September 2019 CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive Director, Alan Trounson Using the tools of biotechnology and immunology to help transforming cancer from…
Companies urged to help with information on RDTI
3 September 2019 AusBiotech is commissioning research to quantify the additionality and spill-over effects of the R&D Tax Incentive (RDTI) and urgently calls on companies to help with information. Full article here.
Australia’s National Digital Health Survey is open!
3 September 2019 Together we can transform the digital health sector in Australia; simply click the button below As Australia’s only dedicated provider of digital health commercialisation support, ANDHealth is seeking input from digital health innovators and companies…
NRMRC Investigator Grants 2019 Outcomes: Factsheet
3 September 2019 Funding outcomes were recently announced for the new Investigator Grant scheme from the National Health and Medical Research Council (NHMRC). As the national peak body for entire health and medical research pipeline, we give our…
Better, easier, safer services to be achieved through public data sharing reform
3 September 2019 Minister for Government Services, Stuart Robert, today announced a major milestone in the Morrison Government’s commitment to improve government service delivery. A discussion paper outlining proposed landmark public data sharing reforms has been released with…
GTG New Board Appointment
2 September 2019 Genetic Technologies is pleased to announce the appointment of Nick Burrows as Non-Executive Director to the board. Mr Burrows is a contemporary independent Non-Executive Director across the Listed, Government and Private sectors with significant expertise…
FDA provides guidance on clinical pathway to marketing application for Revascor in end-stage heart failure patients with an LVAD
Melbourne Australia; 27 August 2019, and New York, USA, 26 August 2019 Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in cellular medicines for inflammatory diseases, announced today positive outcomes from its recent meeting with the United States Food and…
IDT Secures its first Medicinal Cannabis Manufacturing Permit from the Office of Drug Control
27 August 2019 IDT Australia Limited (ASX: IDT) is pleased to announce that the Department of Health – Office of Drug Control has granted the Company its first Medicinal Cannabis Manufacturing Permit under the Narcotic Drugs Act 1967.…
Positive results with Targeted DEP® using antibody fragment in human ovarian cancer model – Starpharma
29 August 2019 Melbourne, Australia: Starpharma today announced that treatment with a novel HER-2 Targeted DEP® conjugate from its internal Targeted DEP® program resulted in tumour regression and 100% survival in a preclinical human ovarian cancer model. This finding builds on…
Next step in Alzheimer’s disease treatment – SVI & Janssen Pharmaceucticals Inc
29 August 2019 SVI has announced the extension of the research and licensing collaboration agreement with Janssen Pharmaceuticals, Inc, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, with focus on Alzheimer’s disease treatment. The objective of…
Melbourne provides a spark for Israeli tech startup SparkBeyond
29 August 2019 Israeli tech startup company SparkBeyond has chosen Melbourne – Australia’s Tech City – for its first office in the country. Founded in 2013, SparkBeyond has built an artificial intelligence (AI) powered data analytics and problem…
